A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03747575 · COMPLETED
Trial details
- NCT number
- NCT03747575
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-06
- Primary completion
- 2020-03-11
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.